Skip to content
Northbank Media science desk Regenerative aesthetics, read at the level of the evidence Reviewed 1 August 2026
Sourcing and manufacture

Sterility, endotoxin and cold chain

Why a product applied to breached skin raises sterility questions, what endotoxin is, and how storage and transport can change a preparation before use.

Section Sourcing and manufactureReviewed 1 August 2026Length 1,341 wordsDesk Northbank Media
Cold vapour drifting across an ordered array of vessels in a dark field
Generated abstraction of cold vapour over an array of vessels. No branding, no specimen.
The short answer

Any preparation applied to skin that has been deliberately breached has a route into tissue, which makes its sterility a clinical question rather than a cosmetic one. Sterility, endotoxin content and the integrity of the cold chain are the three practical safety parameters for a biological preparation of this kind.

Endotoxin deserves particular attention because it is not removed by sterilisation. A preparation can be sterile, meaning free of viable organisms, and still contain bacterial cell wall material capable of provoking an inflammatory response. Sterile and endotoxin-free are different claims and require different tests.

Why this is not a cosmetic question

Cosmetic products are formulated for application to intact skin, where the barrier does the work of keeping material out of tissue. Preservative systems and microbiological limits are designed for that context. The moment a product is applied to skin that has been needled, lasered or otherwise breached, that assumption fails: there is a direct route in.

This is why we treat the sterility of preparations used after barrier disruption as a clinical parameter, and why the questions below are reasonable for a patient to ask. They are not sophisticated questions. They are the ordinary questions asked of anything that enters tissue.

Sterility

Sterility means the absence of viable micro-organisms. It is achieved either by terminal sterilisation of the finished product or by aseptic manufacture, and it is verified by testing. For a biological preparation, terminal sterilisation by heat is generally not an option, because heat destroys the product. Filtration is the usual route, and filtration has a size limit: a filter fine enough to retain bacteria also retains larger particles, which for a vesicle preparation raises the question of what is being removed alongside the organisms.

That tension is worth understanding. A manufacturer sterilising by filtration has to demonstrate both that the filter removes organisms and that it does not remove the product. Those are two validation exercises and a supplier should be able to say they were done.

Endotoxin

Endotoxin is a component of the outer membrane of certain bacteria. It is heat stable and it is not removed by killing the organism. A preparation can therefore be sterile and contain endotoxin, and endotoxin is a potent stimulator of inflammatory responses.

This matters twice over. Clinically, endotoxin introduced into tissue can provoke an inflammatory reaction. Scientifically, it is a notorious confounder in cell culture experiments, because it activates cells and can produce effects that are then attributed to the preparation under study. A laboratory result obtained with an endotoxin-contaminated preparation may be a result about endotoxin.

Evidence panelEP-20

A preparation described as sterile is safe to apply to freshly needled skin.

Proposed mechanism
Sterility means no viable organisms, so no infection risk from the product.
What has been shown
Sterility testing establishes the absence of viable organisms under the conditions tested. It does not address endotoxin, which is heat stable, not removed by killing organisms, and capable of provoking inflammatory responses. Endotoxin testing is a separate assay reported separately.
Highest level reached
Not shown
Main confounders
Sterility test sampling covers a portion of a batch. Cold chain excursions after release can permit growth in a product that was sterile at release if the container is compromised.

GradeNOT SUPPORTED

What would change thisNothing, as stated. The claim conflates two parameters. A supplier reporting both sterility and endotoxin results, with the endotoxin limit stated, addresses the actual question.

Cold chain, and why it is the weakest link

Biological preparations are typically stored frozen or refrigerated, and stability depends on that being maintained. The manufacturing quality of a product is irrelevant if it thawed in transit.

Three failure modes recur across biological products generally.

  • Temperature excursion in transit. Detectable only if a monitor accompanies the shipment. Many do not.
  • Freeze and thaw cycles. Repeated cycles are widely reported to damage vesicle preparations, causing aggregation and loss of integrity. A vial thawed, partly used and refrozen has been through a cycle the stability data may not cover.
  • Storage at the point of use. A clinic freezer opened frequently is a different environment from a validated storage unit, and few clinics monitor and log temperature continuously.

Lyophilised, meaning freeze-dried, products change this picture: they are generally more stable in transit and are reconstituted before use. Reconstitution then becomes the controlled step, with its own questions about diluent, technique and time before use.

Three parameters, three questions
ParameterWhat it establishesThe question to ask
SterilityNo viable organisms at testHow was sterility achieved, and was the method validated for this product?
EndotoxinBacterial membrane material below a limitWhat is the limit, and what did this batch measure?
Cold chainThe product arrived in the state it left inWas temperature monitored in transit, and how is it stored and logged here?

Why handling changes what is delivered

Beyond safety, handling changes the product. If freeze and thaw cycles cause aggregation, then the preparation applied is not the preparation characterised, and any dose reasoning based on the specification no longer holds. Mechanical shear during application, particularly through a fine needle, is a further stress rarely discussed in product literature.

This connects directly to why a nanoparticle count is not a dose. A count measured at manufacture describes the product at manufacture. Between that measurement and the patient sit transport, storage, thawing, possibly dilution, and delivery. Each step can change the material and none of them is usually measured.

What good looks like

A supplier operating properly can state how sterility is achieved and validated, publish an endotoxin limit and batch results against it, provide stability data supporting the stated storage conditions and shelf life, specify how many freeze and thaw cycles the product tolerates, and ship with temperature monitoring. None of that is exotic; it is the ordinary quality architecture of a biological product.

Where it is absent, the absence should be visible to the purchaser rather than assumed away. That is why our listings record these disclosures explicitly, including when a supplier declines to make them.

Questions readers ask

Is sterile the same as safe?

No. Sterility means no viable micro-organisms. Endotoxin, a heat-stable component of some bacterial membranes, is not removed by killing organisms and can provoke inflammatory responses. Sterility and endotoxin are separate parameters with separate tests.

What is endotoxin?

A component of the outer membrane of certain bacteria that is heat stable and can provoke a strong inflammatory response. It is also a well known confounder in cell culture, because it activates cells and can produce effects wrongly attributed to the preparation being tested.

Does freezing and thawing damage these products?

Repeated freeze and thaw cycles are widely reported to damage vesicle preparations, causing aggregation and loss of integrity. A product thawed, partly used and refrozen may fall outside the conditions its stability data covers.

Why does sterility matter more with microneedling?

Because needling creates a direct route into tissue. A product formulated for intact skin relies on the barrier to keep material out; once the barrier is breached that assumption no longer holds.

What should a clinic be able to tell me?

What the product is and its regulatory status for the route being used, whether it is supplied sterile and whether the supplier reports endotoxin, and how it has been stored since arrival. These are the ordinary questions asked of anything entering tissue.

The science briefing

One email a fortnight. What was published in extracellular vesicle and regenerative aesthetics research, what it actually showed, and which claims moved on our grading scale. Written for people who read the methods section.

No spam, unsubscribe in one click. We never pass your address to a third party. See privacy.